Abstract:The incidence of Mycobacterium marinum infection is on the rise; however, the existing drug treatment cycle is lengthy and often requires multi-drug combination. Therefore, there is a need to develop new and effective anti-M. marinum drugs. Cochliomycin A, a 14-membered resorcylic acid lactone with an acetonide group at C-5′ and C-6′, exhibits a wide range of antimicrobial, antimalarial, and antifouling activities. To further explore the effect of this structural change at C-5′ and C-6′ on this compound's activity, we synthesized a series of compounds with a structure similar to that of cochliomycin A, bearing ketal groups at C-5′ and C-6′. The R/S configuration of the diastereoisomer at C-13′ was further determined through an NOE correlation analysis of CH3 or CH at the derivative C-13′ position and the H-5′ and H-6′ by means of a 1D NOE experiment. Further comparative 1H NMR analysis of diastereoisomers showed the difference in the chemical shift (δ) value of the diastereoisomers. The synthetic compounds were screened for their anti-microbial activities in vitro. Compounds 15–24 and 28–35 demonstrated promising activity against M. marinum, with MIC90 values ranging from 70 to 90 μM, closely approaching the MIC90 of isoniazid. The preliminary structure–activity relationships showed that the ketal groups with aromatic rings at C-5′ and C-6′ could enhance the inhibition of M. marinum. Further study demonstrated that compounds 23, 24, 29, and 30 had significant inhibitory effects on M. marinum and addictive effects with isoniazid and rifampicin. Its effective properties make it an important clue for future drug development toward combatting M. marinum resistance.

Biosynthesis of mildiomycin analog and identification of its structure

The Mildiomycin Biosynthesis: Initial Steps for Sequential Generation of 5-Hydroxymethylcytidine 5′-Monophosphate and 5-Hydroxymethylcytosine in<i>Streptoverticillium rimofaciens</i>ZJU5119

Isolation, Purification and Structure Determination of a Novel Antifungal Compound

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Fermentation process and kinetics of novel antifungal antibiotic production

Identification of a Novel Antifungal Strain and Its Biocontrol Effect on Plant Pathogenic Fungi

A New Medermycin Analog from the Marine-Derived Actinomycetes Streptomyces Sp. ZS-A45.

[Extraction and structural identification of the antifungal metabolite of Streptomyces lydicus A02]

Bioactive Metabolites from Marine-Derived Streptomyces Sp A68 and Its Rifampicin Resistant Mutant Strain R-M1

Efficient Separation of Cytosine-Substituted Mildiomycin Analogue (MIL-C) from the Fermentation Broth by Ion Exchange

The biosynthesis and bioactivity evaluation of the cytosine-substituted mildiomycin analogue (MIL-C) for controlling powder mildew

A New Compound from the Marine-Derived Streptomyces Sp. SS13M

Cytotoxic and Antifungal Staurosporine Derivatives from Marine-Derived Actinomycete Streptomyces Sp. ZS-A121

Structure and Biosynthesis of Mayamycin B, a New Polyketide with Antibacterial Activity from Streptomyces Sp. 120454

New analogues of amides and quinolinones produced by Streptomyces sp. YIM S01983

Novel Antimycin Analogues with Agricultural Antifungal Activities from the Sponge-Associated Actinomycete <i>Streptomyces </i>sp. NBU3104

Semisynthesis, Structure Elucidation and Anti-Mycobacterium marinum Activity of a Series of Marine-Derived 14-Membered Resorcylic Acid Lactones with Interesting Ketal Groups

Antibiofilm Metabolites from Marine-derived Streptomyces sp. ZS-A31

Antimicrobial spiroketal macrolides and dichloro-diketopiperazine from Micromonospora sp. FIMYZ51

Mintaimycins, a Group of Novel Peptide Metabolites from Micromonospora sp. C-3509

Discovery, Biosynthesis, and Heterologous Production of Streptoseomycin, an Anti-Microaerophilic Bacteria Macrodilactone